Dongcheng Biochem
00267512.820.23% ( +0.03 )
Dongcheng Biochem (002675)
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationa...
- Open
- 12.73
- High
- 12.90
- Low
- 12.72
- Prev. Close
- 12.79
- Volume
- 66.72K
- Turnover
- 85.63M
- Avg Price
- 12.83
- Bid/Ask Ratio
- --
- Amplitude
- 1.41%
- 52wk High
- 18.60
- Volume Ratio
- 0.47
- Turnover Ratio
- 0.81%
Dongcheng Biochem Analyst Rating
View MoreForecast & Rating
Jun 24, 2026Price forecast
¥18.0040.41%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- SCMP · Mar 26 at 12:31 AM
China’s Jiangsu Aidea eyes Hong Kong IPO as gateway to US, European Aids markets
- Zhitong · Sep 29, 2025 at 11:01 PM
Dongcheng Biochem's subsidiary Lanacheng has submitted an application for the issuance and listing of H shares
- Zhitong · Sep 23, 2025 at 04:21 AM
Dongcheng Biochem: 225Ac-LNC1011 injection has received clinical trial approval
- Zhitong · Aug 28, 2025 at 08:44 AM
Dongcheng Biochem: Plans to spin off its subsidiary Lanacheng for listing on the main board of the Hong Kong Stock Exchange
- Zhitong · Aug 21, 2025 at 10:54 PM
Dongcheng Biochem's subsidiary has received the drug clinical trial approval notice
- Zhitong · Aug 14, 2025 at 05:12 AM
Dongcheng Biochem: Net profit of 88.6525 million yuan in the first half of 2025, a year-on-year decrease of 20.70%
